AMAG Pharmaceuticals Price/Sales
Cos'è Price/Sales di AMAG Pharmaceuticals?
Price/Sales di AMAG Pharmaceuticals, Inc. è 1.57
Qual è la definizione di Price/Sales?
Il rapporto prezzo / vendite è il prezzo delle azioni di una società rispetto ai suoi ricavi.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales di aziende nel Health Care settore su NASDAQ rispetto a AMAG Pharmaceuticals
Cosa fa AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Aziende con price/sales simili a AMAG Pharmaceuticals
- Louisiana-Pacific ha Price/Sales di 1.57
- Voyager Therapeutics Inc ha Price/Sales di 1.57
- SoFi Technologies ha Price/Sales di 1.57
- Colfax Corp ha Price/Sales di 1.57
- Chevron ha Price/Sales di 1.57
- Seagate Technology plc ha Price/Sales di 1.57
- AMAG Pharmaceuticals ha Price/Sales di 1.57
- Rexnord Electronics and Controls ha Price/Sales di 1.57
- Xponential Fitness ha Price/Sales di 1.57
- Religare Enterprises ha Price/Sales di 1.57
- Aviva Plc ha Price/Sales di 1.57
- Atul Auto ha Price/Sales di 1.57
- The South Indian Bank ha Price/Sales di 1.57